The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...

Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...

The ongoing drama in Washington over changes to national vaccine policy has many people wondering just how difficult and ...

The Pfizer vaccine is the first to receive FDA approval, while the Moderna and Johnson & Johnson vaccines are available under an emergency use authorization. For children ages 12 to 15, Pfizer's ...

Pfizer is the first of several companies to report results from ongoing late-stage trials. Moderna, another company in the race for a vaccine, launched a trial on July 27 -- the same day as Pfizer.

A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic in Chester, Pa., on Dec. 15, 2021. Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is ...

Pfizer's vaccine is successful in preventing not only symptomatic COVID-19, but also asymptomatic disease according to new real-world data, Israel's Ministry of Health and Pfizer/BioNTech ...